These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24126603)

  • 1. Immunogenicity of hypothetical highly conserved proteins as novel antigens in Anaplasma marginale.
    Nuñez PA; Moretta R; Ruybal P; Wilkowsky S; Farber MD
    Curr Microbiol; 2014 Mar; 68(3):269-77. PubMed ID: 24126603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subdominant Outer Membrane Antigens in Anaplasma marginale: Conservation, Antigenicity, and Protective Capacity Using Recombinant Protein.
    Ducken DR; Brown WC; Alperin DC; Brayton KA; Reif KE; Turse JE; Palmer GH; Noh SM
    PLoS One; 2015; 10(6):e0129309. PubMed ID: 26079491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine.
    Lopez JE; Palmer GH; Brayton KA; Dark MJ; Leach SE; Brown WC
    Infect Immun; 2007 May; 75(5):2333-42. PubMed ID: 17339347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subdominant antigens in bacterial vaccines: AM779 is subdominant in the Anaplasma marginale outer membrane vaccine but does not associate with protective immunity.
    Albarrak SM; Brown WC; Noh SM; Reif KE; Scoles GA; Turse JE; Norimine J; Ueti MW; Palmer GH
    PLoS One; 2012; 7(9):e46372. PubMed ID: 23029498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of Outer Membrane Proteins VirB9-1 and VirB9-2, a Novel Nanovaccine against Anaplasma marginale.
    Zhao L; Mahony D; Cavallaro AS; Zhang B; Zhang J; Deringer JR; Zhao CX; Brown WC; Yu C; Mitter N; Middelberg AP
    PLoS One; 2016; 11(4):e0154295. PubMed ID: 27115492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaplasma marginale outer membrane protein vaccine candidates are conserved in North American and South African strains.
    Hove P; Brayton KA; Liebenberg J; Pretorius A; Oosthuizen MC; Noh SM; Collins NE
    Ticks Tick Borne Dis; 2020 Jul; 11(4):101444. PubMed ID: 32336660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning, sequencing and antigenic characterization of rVirB9 of Anaplasma marginale isolated from Paraná State, Brazil.
    Vidotto MC; Venâncio EJ; Vidotto O
    Genet Mol Res; 2008; 7(2):460-6. PubMed ID: 18561379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of B-cell epitopes in the N-terminal repeated peptides of Anaplasma marginale major surface protein 1a and characterization of the humoral immune response of cattle immunized with recombinant and whole organism antigens.
    Garcia-Garcia JC; de la Fuente J; Kocan KM; Blouin EF; Halbur T; Onet VC; Saliki JT
    Vet Immunol Immunopathol; 2004 Apr; 98(3-4):137-51. PubMed ID: 15010223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Anaplasma marginale outer membrane protein antigens conserved between A. marginale sensu stricto strains and the live A. marginale subsp. centrale vaccine.
    Agnes JT; Brayton KA; LaFollett M; Norimine J; Brown WC; Palmer GH
    Infect Immun; 2011 Mar; 79(3):1311-8. PubMed ID: 21189322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multistrain genome analysis identifies candidate vaccine antigens of Anaplasma marginale.
    Dark MJ; Al-Khedery B; Barbet AF
    Vaccine; 2011 Jul; 29(31):4923-32. PubMed ID: 21596083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linkage between Anaplasma marginale outer membrane proteins enhances immunogenicity but is not required for protection from challenge.
    Noh SM; Turse JE; Brown WC; Norimine J; Palmer GH
    Clin Vaccine Immunol; 2013 May; 20(5):651-6. PubMed ID: 23446216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of enzyme-linked immunosorbent assays based on recombinant MSP1a and MSP2 of Anaplasma marginale.
    Araújo FR; Melo VS; Ramos CA; Madruga CR; Soares CO; Kessler RH; Almeida NF; Araújo GS; Alves LC; Torres Júnior RA; Fragoso SP; Arauco PR; Bacanelli G; Oliveira MB; Santos LR
    Mem Inst Oswaldo Cruz; 2005 Nov; 100(7):765-9. PubMed ID: 16410967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and immune recognition of the conserved MSP4 outer membrane protein of Anaplasma marginale.
    Oberle SM; Palmer GH; Barbet AF
    Infect Immun; 1993 Dec; 61(12):5245-51. PubMed ID: 7693596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput identification of T-lymphocyte antigens from Anaplasma marginale expressed using in vitro transcription and translation.
    Lopez JE; Beare PA; Heinzen RA; Norimine J; Lahmers KK; Palmer GH; Brown WC
    J Immunol Methods; 2008 Mar; 332(1-2):129-41. PubMed ID: 18243240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence and immunologic conservation of Anaplasma marginale OmpA within strains from Ghana as compared to the predominant OmpA variant.
    Futse JE; Buami G; Kayang BB; Koku R; Palmer GH; Graça T; Noh SM
    PLoS One; 2019; 14(7):e0217661. PubMed ID: 31291256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning, sequencing, expression, and antigenic characterization of rMSP4 from Anaplasma marginale isolated from Paraná State, Brazil.
    Kawasaki PM; Kano FS; Vidotto O; Vidotto MC
    Genet Mol Res; 2007 Jan; 6(1):15-22. PubMed ID: 17278086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced immune response of DNA vaccine encoding an association MSP1a, MSP1b, and MSP5 antigens of Anaplasma marginale.
    Kano FS; Tamekuni K; Coelho AL; Garcia JL; Vidotto O; Itano EN; Vidotto MC
    Vaccine; 2008 Jun; 26(27-28):3522-7. PubMed ID: 18502005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaplasma marginale superinfection attributable to pathogen strains with distinct genomic backgrounds.
    Vallejo Esquerra E; Herndon DR; Alpirez Mendoza F; Mosqueda J; Palmer GH
    Infect Immun; 2014 Dec; 82(12):5286-92. PubMed ID: 25287920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection for simple major surface protein 2 variants during Anaplasma marginale transmission to immunologically naïve animals.
    Palmer GH; Futse JE; Leverich CK; Knowles DP; Rurangirwa FR; Brayton KA
    Infect Immun; 2007 Mar; 75(3):1502-6. PubMed ID: 17178787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular conservation of MSP4 and MSP5 in Anaplasma marginale and A. centrale vaccine strain.
    Molad T; Brayton KA; Palmer GH; Michaeli S; Shkap V
    Vet Microbiol; 2004 May; 100(1-2):55-64. PubMed ID: 15135513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.